UnitedHealth Group Incorporated (UNH)
| Market Cap | 250.15B -43.9% |
| Revenue (ttm) | 447.57B +11.8% |
| Net Income | 12.06B -16.3% |
| EPS | 13.23 -14.7% |
| Shares Out | 907.68M |
| PE Ratio | 20.83 |
| Forward PE | 15.43 |
| Dividend | $8.84 (3.21%) |
| Ex-Dividend Date | Mar 9, 2026 |
| Volume | 38,975,203 |
| Open | 278.99 |
| Previous Close | 280.44 |
| Day's Range | 275.00 - 283.10 |
| 52-Week Range | 234.60 - 606.36 |
| Beta | 0.38 |
| Analysts | Buy |
| Price Target | 387.79 (+40.71%) |
| Earnings Date | Apr 21, 2026 |
About UNH
UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. It operates through four segments: Optum Health, Optum Insight, Optum Rx; and UnitedHealthcare. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services with patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities. The Optum Insight segment offers software and information products, advisory consulting arrangements, and man... [Read more]
Financial Performance
In 2025, UnitedHealth Group's revenue was $447.57 billion, an increase of 11.81% compared to the previous year's $400.28 billion. Earnings were $12.06 billion, a decrease of -16.31%.
Financial StatementsAnalyst Summary
According to 25 analysts, the average rating for UNH stock is "Buy." The 12-month stock price target is $387.79, which is an increase of 40.71% from the latest price.
News
Goldman Sachs Large Cap Value Fund: Q4 2025 Portfolio Attribution And Review
During the fourth quarter of 2025, the Goldman Sachs Large Cap Value Fund underperformed the Russell 1000 Value Index ((net)). Alphabet released its third quarter earnings results, in which it deliver...
Warren Buffett, Markwayne Mullin Bet On The Same 10 Stocks – Some Might Surprise You
So which seven stocks are common to both Berkshire Hathaway and Mullin's portfolio? Here's the full list, based on the Benzinga Government Trades page for Mullin.
UnitedHealth, Hims & Hers, Gambling.Com - Value Investing With Raul Shah
Raul Shah from DocShah Financial shares his bullishness on top holdings, Hims & Hers (HIMS), UnitedHealth (UNH), and Gambling.com (GAMB). Tax gain harvesting and more tax takeaways for investors.
UnitedHealth Group Announces Earnings Release Date
--(BUSINESS WIRE)--UnitedHealth Group (NYSE: UNH) will release its first quarter 2026 financial results on Tuesday, April 21, 2026, before the market opens, and will host a teleconference at 8:00 a.m....
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 3% Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
UnitedHealth: Stabilizing, But Not Yet A Buy
UnitedHealth Group is rated a Hold, with no immediate catalyst for accumulation, as stabilization, not turnaround, is expected in 2026. UNH's revenue and membership declines reflect strategic resets, ...
UnitedHealth Group: Still A Generational Buying Opportunity
UnitedHealth Group remains a generational buying opportunity, with shares trading at a compelling 16.6x forward earnings and with robust long-term prospects. MCRs have likely bottomed out, with manage...
UnitedHealth: Why AI Is The Secret Weapon For The Turnaround
UnitedHealth Group receives a buy rating, driven by attractive valuation and management's focus on efficiency and cost reduction, particularly through AI initiatives. UNH guides for 2026 EPS above $17...
UnitedHealthcare Expands Doula Offering to Employer-Sponsored Plans Nationwide
--(BUSINESS WIRE)--UnitedHealthcare today announced the national expansion of its doula offering, now available to people enrolled in eligible health plans through their employer. Doula Support is des...
UnitedHealth Group Incorporated (UNH) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
UnitedHealth Group Incorporated (UNH) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Harbor Health Care ETF Q4 2025 Portfolio Review
Revolution Medicines was a top contributor during the quarter. AbbVie, by contrast, traded largely sideways, as investors continued to assess its post-patent earnings durability. While Eli Lilly deliv...
Hadley and UnitedHealthcare Vision Collaborate to Expand Emotional Support for Vision Loss
WINNETKA, Ill.--(BUSINESS WIRE)-- #HadleyHelps--Hadley is working with UnitedHealthcare Vision to help ensure that more people experiencing vision loss have access to emotional support resources along...
UnitedHealth: A Golden Buying Opportunity (Rating Upgrade)
UnitedHealth is upgraded to 'Buy' as pessimism appears overdone and shares trade near a strong $300 support with compelling valuation metrics. UNH's scale, AI-driven cost efficiencies, and exposure to...
5 Dividend Stocks Beating Tech in 2026
David Bahnsen, Chief Investment Officer, The Bahnsen Group shares the five stocks he thinks offer real upside as investors move away from Big Tech — and where he sees the strongest opportunities now. ...
Is The Bottom In For UNH Stock After Its Dramatic 23% Slide?
UnitedHealth (UNH) stock has dropped by 23.1% in under a month, from $356 on January 23, 2026 to $274 now, primarily due to a "perfect storm" of disappointing 2026 financial guidance and a major regul...
UnitedHealth Group Board Authorizes Payment of Quarterly Dividend
--(BUSINESS WIRE)--UNH Quarterly Dividend Announcement.
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
UnitedHealth Chief Made Private Side Bets on Healthcare Startups
Stephen Hemsley took unannounced stakes through affiliates of his investment firm. UnitedHealth says he abides by conflict-of-interest policies.
UnitedHealth: 3 Reasons Not To Buy (Revisited)
UnitedHealth remains exposed to medical cost inflation and government funding constraints pressuring margins and limiting premium rate increases. After a post-earnings drop, UNH still trades at 15x 20...
Is There More Downside To UNH Stock?
UnitedHealth (UNH) stock has decreased by 18.1% over the last 21 trading days. The recent decline stems from renewed worries regarding proposed flat Medicare Advantage rates and escalating medical cos...
UnitedHealth: After The Collapse
UnitedHealth guides 2026 revenue to $439 billion, down from $448 billion, marking its first annual decline in decades. Operating cash flow remains robust near $18 billion, supported by $19.7 billion t...
Can UNH Stock Surge Again?
UnitedHealth has shown substantial rally potential, with several occurrences of gains exceeding 30% in less than two months noted in key years 2010, 2019, 2020, 2021, and 2025, notwithstanding the rec...
UnitedHealth Group FQ4 Earnings: Why Top Analysts Ask About Its Margin
During UnitedHealth Group FQ4 2025 earnings call, multiple analysts from leading institutions asked questions about the ongoing margin pressure. UNH's margins are below both sector and historical aver...
UnitedHealth: Buy The Dip As Multiple Factors Could Drive Strong Long-Term Returns
UnitedHealth Group offers a compelling buy-the-dip opportunity below $300, supported by strong management and a resilient long-term growth profile. UNH's recent selloff, triggered by a proposed Medica...
Does UNH Stock Still Deserve Its Premium Valuation?
While UnitedHealth Group (NYSE: UNH) has long commanded a premium for its industry-leading stability, the stock has notably lagged behind competitors over the past year. The market is now reassessing ...